Vibrotactile Coordinated Reset for Parkinson's Disease
This study is testing a new, non-invasive device called the Stanford Glove for people with Parkinson's disease. The glove delivers gentle vibrations to your fingertips. Researchers want to see if this 'Vibrotactile Coordinated Reset' (vCR) stimulation can help improve Parkinson's symptoms. This approach aims to be an alternative to common treatments like Levodopa or deep brain stimulation. You might be able to join if you are between 35 and 92 years old, have idiopathic Parkinson's (meaning the cause is unknown) at certain stages, speak English, and are comfortable using a computer for virtual meetings. The main goal is to measure changes in your Parkinson's symptoms after 6 months using a standard rating scale.
- Study design
- This interventional study plans to enroll 20 participants. It is evaluating the effects of the Stanford Glove device.
- What's involved
- Participants will use the Stanford Glove device. You will need to be comfortable with technology for virtual training and monitoring.
- Compensation
- Not stated in the trial record.
- Follow-up
- Patients will be followed for two years after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population
At a glance
Conditions
NCT06029686
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Stanford University
Stanford, Californiano site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Peter A Tass, MD, PhD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in Parkinsonian symptoms as defined by the change in Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III Score6 months
Change in MDS-Unified Parkinson's Disease Rating Scale Part III Scale Score Mean change in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III score. Minimum score - 0 indicates normal functioning Maximum score - 132 indicated severe impairment Lower scores indicate greater functionality and higher scores indicate severe impairment in functionality.